Month: August 2022

Fortress Transportation and Infrastructure Investors LLC Announces Merger Which Will Eliminate Its Partnership Tax Classification and Result in the Public Entity Being a Corporation

Written by Customer Service on August 15, 2022. Posted in Mergers And Acquisitions.

NEW YORK, Aug. 15, 2022 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (NASDAQ: FTAI), a Delaware limited liability company (“FTAI” or the “Company”) announced today that it had entered into a definitive agreement to merge with a subsidiary of FTAI Finance Holdco Ltd., a Cayman Islands exempted company and subsidiary of the Company, with FTAI surviving the merger and becoming a wholly-owned subsidiary of FTAI Finance Holdco Ltd. Following the completion of the merger, FTAI Finance Holdco Ltd. will be named FTAI Aviation Ltd. (“FTAI Aviation”). The transaction is being completed as part of the Company’s plan to eliminate its partnership tax classification. The surviving entity in the merger, FTAI Aviation, is a corporation. Thus, if the merger is completed, shareholders will no longer receive Form K-1s. In...

Viridian Announces Positive Initial Clinical Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)

Written by Customer Service on August 15, 2022. Posted in Public Companies.

– Significant and rapid improvement in both signs and symptoms of TED at week 6 after two infusions of 10mg/kg VRDN-001 – – Proptosis response achieved by 83% of patients with a mean reduction of 2.4mm from baseline – – Clinical Activity Score (CAS) of 0 or 1 achieved by 83% of patients with a mean reduction of 4.3 points from baseline – – Complete resolution of diplopia achieved by 75% of patients with diplopia at baseline – – VRDN-001 demonstrated a favorable safety and tolerability profile with no reported SAEs, no hyperglycemia, and no infusion reactions – – 20mg/kg cohort enrollment nearly complete, with planned data presentation at a medical meeting in 4Q22; 3mg/kg cohort is on track for data in 4Q22 – – VRDN-002 achieved a substantially...

Wabash to Participate in Raymond James Diversified Industrials Conference

Written by Customer Service on August 15, 2022. Posted in Public Companies.

LAFAYETTE, Ind., Aug. 15, 2022 (GLOBE NEWSWIRE) — Wabash (NYSE:WNC), the innovation leader of connected solutions for the transportation, logistics and distribution industries, today announced it will participate in the Raymond James Diversified Industrials Conference on August 23, 2022, in New York City. Senior Vice President and Chief Financial Officer Mike Pettit will participate in a fireside chat at 8:00 a.m. ET, where he is expected to discuss Wabash’s refreshed strategy and growth initiatives that drive toward the company’s previously announced 2025 financial targets of $3.0B in revenue, 11% EBITDA margin and $3.50 EPS. To access the live or archived webcast, visit the Investor Relations section of Wabash’s website at ir.onewabash.com. Wabash: Changing How the World Reaches YouAs the innovation leader of connected solutions...

atai Life Sciences Secures Term Loan Facility for up to $175 Million from Hercules Capital

Written by Customer Service on August 15, 2022. Posted in Public Companies.

– Non-dilutive financing facility, plus $312M existing cash on hand as of June 30, 2022, gives atai access to up to $487M to continue developing next generation mental health treatments – Flexible draw availability provides optionality to optimize liquidity and capital structure moving forward NEW YORK and BERLIN, Aug. 15, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the company has entered into a term loan facility for up to $175 million with Hercules Capital, Inc. (NYSE: HTGC). “The non-dilutive capital from this term loan facility combined with the cash already on our balance sheet further reinforces atai’s financial strength, providing us with strategic flexibility...

Euro Manganese Reports Third Quarter 2022 Financial Results and Project Developments

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Aug. 15, 2022 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the “Company” or “EMN“) is pleased to announce key developments during the third fiscal quarter 2022 and to date. The Company has now filed its third quarter Financial Statements and Management’s Discussion and Analysis (“MD&A“). Key Developments During and Subsequent to the Quarter:Positive Feasibility Study (“FS”) announced for the Chvaletice Manganese Project (“the Project“). The FS outlines robust base case project economics of after-tax NPV8% of US1.34 billion and an ungeared IRR of 21.9% with a 4.1-year payback period. Initial capital is estimated at US$757.3 million, including total contingencies of $106.5 million. Forecast...

Rubicon Organics Reports Second Quarter 2022 Financial Results

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

Record sales, first quarter of profitability and growing share of premium market$8.8 million in net revenue, 92% increase over Q2 2021 Achieved Adjusted EBITDA1 of $0.3 million in Q2 2022 2.7%2 national market share of flower and pre-rolls 8.6%3 national market share of premium flower and pre-rollsVANCOUVER, British Columbia, Aug. 15, 2022 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, today reported its financial results for the second quarter ended June 30, 2022 (“Q2 2022”). All amounts are expressed in Canadian dollars. “Rubicon Organics has reached profitability due to the continued success of Simply Bare™ Organic as Canada’s #1 premium flower and pre-roll brand3 and the...

embecta Announces Inaugural Quarterly Cash Dividend

Written by Customer Service on August 15, 2022. Posted in Dividend Reports And Estimates.

PARSIPPANY, N.J., Aug. 15, 2022 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies, announced today that its Board of Directors declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on September 14, 2022 to stockholders of record at the close of business on August 26, 2022. About embecta embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com. CONTACTS Investors:Pravesh...

Eliem Therapeutics Reports Second Quarter Financial and Business Highlights

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

Initiated Phase 1 pharmacokinetic trial for ETX-155 with expected results in Q4 2022 Capital now expected to fund operations into 2025 SEATTLE and CAMBRIDGE, United Kingdom, Aug. 15, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems, today provided a business update and reported financial results for the quarter ended June 30, 2022. “We continue to advance our pipeline targeting neuronal excitability disorders,” said Bob Azelby, president and chief executive officer of Eliem Therapeutics. “While we are disappointed with our recent announcement regarding the discontinuation of...

Kvika banki hf.: Publication of H1 financial results and investor presentation on Thursday 18 August

Written by Customer Service on August 15, 2022. Posted in Earnings Releases And Operating Results.

The board of directors of Kvika banki hf. is set to approve the financial statements of the Group for the first six months of 2022 at a board meeting on Thursday 18 August. The financial statements will subsequently be published after domestic markets have closed. A meeting to present the results to shareholders and market participants will be held the same day, at 16:15 GMT on Thursday 18 August, at the bank’s headquarters on the 9th floor at Katrínartún 2, 105 Reykjavík. The presentation will be conducted in Icelandic and will be streamed live. Further, a recording of the meeting with English subtitles will later be made available on Kvika’s website. Meeting participants will be able to send questions before or during the meeting via fjarfestatengsl@kvika.is The investor presentation will be made public before the meeting.

Li Auto Inc. Announces Unaudited Second Quarter 2022 Financial Results

Written by Customer Service on August 15, 2022. Posted in Public Companies.

Quarterly total revenues reached RMB8.73 billion (US$1.30 billion)1Quarterly deliveries reached 28,687 vehiclesQuarterly gross margin reached 21.5% BEIJING, China, Aug. 15, 2022 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced its unaudited financial results for the quarter ended June 30, 2022. Operating Highlights for the Second Quarter of 2022Deliveries of Li ONE were 28,687 vehicles in the second quarter of 2022, representing a 63.2% year-over-year increase.Deliveries2022 Q2 2022 Q1 2021 Q4 2021 Q328,687 31,716 35,221 25,116 Deliveries2021 Q2 2021 Q1 2020 Q4 2020 Q317,575 12,579 14,464 8,660As of June 30, 2022, the Company had 247 retail stores covering 113 cities, as...

Month: August 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals